According to the UK Summary of Product Characteristics (SmPC) and data submitted to regulatory authorities including the Medicines and Healthcare products Regulatory Agency (MHRA) and the European Medicines Agency (EMA) , injection site reactions are classified as a common adverse effect of Mounjaro (affecting between 1 in 10 and 1 in 100 patients)
3. Reduccin de la fatiga muscular
THNH PHN: Glutathione 2%, gip m thm v dng da trng sng mn mng, chng lo ho da Alpha Arbutin 2% gip c ch sn xut melanin, lm sng da hiu qu Niacinamide 5% s ngn chn hnh thnh vi khun gy mi, c ch iu tit tuyn m hi ln n 72 gi
Change history 16 November 2011 This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication References Adams TE, Epa VC, Garrett TP, Ward CW (2000) Structure and function of the type 1 insulin-like growth factor receptor
Some patients report subjective preferences: for instance, those with more subcutaneous tissue in the abdomen may find it more comfortable than the thigh, or vice versa